FINEARTS-HF trial results in clinically meaningful reduction in the composite endpoint of CV death Read more
Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says GlobalData Read more
NewAmsterdam’s obicetrapib holds potential to become first CETP inhibitor to advance to clinical practice: GlobalData Read more
Pfizer’s gene therapy for Haemophilia A receives positive topline results from Phase 3 Study Read more
Synergistic safety profile could increase sublingual apomorphine competitiveness: GlobalData Read more